A
Andrew Fuller
Researcher at Alfred Hospital
Publications - 26
Citations - 1635
Andrew Fuller is an academic researcher from Alfred Hospital. The author has contributed to research in topics: Transplantation & Antibody. The author has an hindex of 13, co-authored 26 publications receiving 1507 citations. Previous affiliations of Andrew Fuller include Monash University & Royal Perth Hospital.
Papers
More filters
Journal ArticleDOI
Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
Benjamin P Howden,Peter B. Ward,Patrick G. P. Charles,Tony M. Korman,Andrew Fuller,Philipp du Cros,Elizabeth A Grabsch,Sally A. Roberts,Jenny Robson,Kerry Read,Narin Bak,James C. Hurley,Paul D R Johnson,Arthur J. Morris,Barrie C. Mayall,M Lindsay Grayson,M Lindsay Grayson +16 more
TL;DR: Antibiotic therapy, especially linezolid with or without rifampicin and fusidic acid, in conjunction with surgical debulking is effective therapy for the majority of patients with serious infections (including endocarditis) caused by SA-RVS.
Journal ArticleDOI
SMART-COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community-Acquired Pneumonia
Patrick G. P. Charles,Rory Wolfe,Michael Whitby,Michael J. Fine,Andrew Fuller,Robert G Stirling,Alistair Alexander Wright,Julio A. Ramirez,Keryn J. Christiansen,Grant W. Waterer,Robert J Pierce,John G. Armstrong,Tony M. Korman,Peter Holmes,Scott D Obrosky,Paula Peyrani,Barbara Johnson,Michelle Hooy,M Lindsay Liindsay Grayson,M Lindsay Liindsay Grayson +19 more
TL;DR: SMART-COP is a simple, practical clinical tool for accurately predicting the need for IRVS that is likely to assist clinicians in determining CAP severity.
Journal ArticleDOI
Isolation of a Novel Orientia Species (O. chuto sp. nov.) from a Patient Infected in Dubai
Leonard Izzard,Leonard Izzard,Andrew Fuller,Stuart D. Blacksell,Stuart D. Blacksell,Daniel H. Paris,Daniel H. Paris,Allen L. Richards,Allen L. Richards,Allen L. Richards,Nuntipa Aukkanit,Nuntipa Aukkanit,Chelsea Nguyen,Ju Jiang,Stan Fenwick,Nicholas P. J. Day,Stephen Graves,John Stenos,John Stenos +18 more
TL;DR: The molecular divergence and geographically unique origin lead us to believe that this organism should be considered a novel species and the name “Orientia chuto,” and the prototype strain is strain Dubai, named after the location in which the patient was infected.
Journal ArticleDOI
The Etiology of Community-Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
Patrick G. P. Charles,Michael Whitby,Andrew Fuller,Robert G Stirling,Alistair Alexander Wright,Tony M. Korman,Peter Holmes,Keryn J. Christiansen,Grant W. Waterer,Robert J Pierce,Barrie C. Mayall,John G. Armstrong,Michael G. Catton,Graeme R. Nimmo,Graeme R. Nimmo,Barbara Johnson,Michelle Hooy,M. L. Grayson,M. L. Grayson +18 more
TL;DR: The vast majority of patients with CAP can be treated successfully with narrow-spectrum beta-lactam treatment, such as penicillin combined with doxycycline or a macrolide, and greater use of such therapy could potentially reduce the emergence of antibiotic resistance among common bacterial pathogens.
Journal ArticleDOI
Balamuthia mandrillaris brain abscess successfully treated with complete surgical excision and prolonged combination antimicrobial therapy
Joseph Doyle,Emer Campbell,Andrew Fuller,Denis Spelman,Rhoda Cameron,Grregory Malham,Douglas L. Gin,Sharon R Lewin,Sharon R Lewin +8 more
TL;DR: This case describes successful treatment of a Balamuthia mandrillaris brain abscess using prolonged antimicrobial agents with complete excision and illustrates the risk of dissemination from cutaneous to cerebral amoebic lesions, potential progression with corticosteroid therapy, and the prospect for curative excision.